1. Home
  2. IMRN vs AWX Comparison

IMRN vs AWX Comparison

Compare IMRN & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • AWX
  • Stock Information
  • Founded
  • IMRN 1994
  • AWX 1998
  • Country
  • IMRN Australia
  • AWX United States
  • Employees
  • IMRN N/A
  • AWX N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • AWX Environmental Services
  • Sector
  • IMRN Health Care
  • AWX Utilities
  • Exchange
  • IMRN Nasdaq
  • AWX Nasdaq
  • Market Cap
  • IMRN 9.2M
  • AWX 9.5M
  • IPO Year
  • IMRN N/A
  • AWX 1998
  • Fundamental
  • Price
  • IMRN $1.74
  • AWX $2.49
  • Analyst Decision
  • IMRN Strong Buy
  • AWX
  • Analyst Count
  • IMRN 1
  • AWX 0
  • Target Price
  • IMRN $5.00
  • AWX N/A
  • AVG Volume (30 Days)
  • IMRN 24.7K
  • AWX 19.6K
  • Earning Date
  • IMRN 07-07-2025
  • AWX 08-07-2025
  • Dividend Yield
  • IMRN N/A
  • AWX N/A
  • EPS Growth
  • IMRN N/A
  • AWX N/A
  • EPS
  • IMRN N/A
  • AWX 0.20
  • Revenue
  • IMRN $4,048,286.00
  • AWX $81,005,000.00
  • Revenue This Year
  • IMRN N/A
  • AWX N/A
  • Revenue Next Year
  • IMRN N/A
  • AWX N/A
  • P/E Ratio
  • IMRN N/A
  • AWX $11.92
  • Revenue Growth
  • IMRN 82.90
  • AWX N/A
  • 52 Week Low
  • IMRN $1.50
  • AWX $2.07
  • 52 Week High
  • IMRN $2.87
  • AWX $3.99
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 58.70
  • AWX 46.70
  • Support Level
  • IMRN $1.68
  • AWX $2.36
  • Resistance Level
  • IMRN $1.94
  • AWX $2.48
  • Average True Range (ATR)
  • IMRN 0.09
  • AWX 0.10
  • MACD
  • IMRN 0.02
  • AWX 0.01
  • Stochastic Oscillator
  • IMRN 76.92
  • AWX 69.45

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

Share on Social Networks: